Onset of antidepressant action: a pharmacological question?

被引:10
作者
Rojo, JE
Gibert, K
Cobo, J
Rodriguez-Cano, E
Vallejo, J
机构
[1] Hosp Univ Bellvitge, Serv Psiquiatria, Hosp Llobregat, Dept Psychiat, Barcelona 08907, Spain
[2] Tech Univ Catalonia, Stat & Operat Res Dept, Barcelona, Spain
[3] Corp Sanit Parc Tauli, Dept Mental Hlth, Barcelona, Spain
[4] St Boi Llobregat, Benito Menni Mental Hlth Inst, Barcelona, Spain
关键词
onset of action; mirtazapine; fast response;
D O I
10.1002/hup.708
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective This study was conducted to analyse the onset of action of antidepressants in naturalistic conditions. Method Multicenter, prospective, open-label, non-comparative naturalistic study among 582 depressed outpatients treated with mirtazapine. The patients were assessed at screening, and after 1, 2 and 4 weeks by the 17-item Hamilton depression rating scale (17-HAM-D) and clinical global impression (CGI). Onset of action was measured by traditional analyses based on the time to a persistent reduction of more than 50% from baseline on the 17-HAM-D. Patients were grouped into four groups: very fast responders, fast responders, traditional responders and partial or non-responders. The non-parametric Kruskall-Wallis test was used to assess differences between the groups and logistic regression to predict response after 1 week of treatment. Results 16% of patients had a very fast response, 42.1% a fast response, 26.5% a traditional response and 15.5% a partial or non-response. There were no significant differences between these groups with regard to dose of mirtazapine or sociodemographic characteristics. The baseline total 17-HAM-D was lower in the faster groups than in the slower groups. The evolution of 17-HAM-D items was similar in each responder group. Conclusion Time to response varied from early faster response to late slower response. The evolution of 17-HAM-D for each type of response was similar, but occurred at a different time in each group. Copyright (c) 2005 John Wiley & Sons, Ltd.
引用
收藏
页码:425 / 433
页数:9
相关论文
共 30 条
[1]  
[Anonymous], INT CLIN PSYCHOPH S3
[2]  
Burke M.J., 1995, PSYCHOPHARMACOLOGY 4
[3]  
COBO JV, 2002, EUR COLL NEUR 15 ANN
[4]  
COBO JV, 2000, IRTAZAPINA RAPIDEZ A
[5]  
DANJOU P, 1994, INT ACAD B, V9, P136
[6]   Mirtazapine - A review of its pharmacology and therapeutic potential in the management of major depression [J].
Davis, R ;
Wilde, MI .
CNS DRUGS, 1996, 5 (05) :389-402
[7]  
deBoer T, 1996, J CLIN PSYCHIAT, V57, P19
[8]  
GELENBERG AJ, 2000, J CLIN PSYCHIAT, V61, P10
[9]   FACTORS AFFECTING THE DELAY OF ANTIDEPRESSANT EFFECT IN RESPONDERS TO NORTRIPTYLINE AND PHENELZINE [J].
GEORGOTAS, A ;
MCCUE, RE ;
COOPER, TB ;
NAGACHANDRAN, N ;
FRIEDHOFF, A .
PSYCHIATRY RESEARCH, 1989, 28 (01) :1-9
[10]   Antidepressants and suicide risk in the United States, 1985-1999 [J].
Grunebaum, MF ;
Ellis, SP ;
Li, SH ;
Oquendo, MA ;
Mann, JJ .
JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 (11) :1456-1462